HR 302

A Resolution ensuring greater access to sickle cell disease treatments and designating the Department of Health to conduct a comprehensive and coordinated data collection effort to better understand and quantify the scope and impact of sickle cell disease on patients, communities and states throughout the United States.

In committee Last action September 4, 2025: Referred to Health

Official bill page and text: palegis.us

Sponsors 12

Prime sponsor: Greg Scott
Cosponsors (11): Ben Waxman, Benjamin Sanchez, Carol Hill-Evans, Dan Williams, Jeanne Mcneill, Jill Cooper, Johanny Cepeda-Freytiz, Jose Giral, Joseph Hohenstein, La'Tasha Mayes, Patrick Harkins

Status

In committee as of September 4, 2025. Session ends November 30, 2026; the 2027–2028 session begins in January 2027.

Roll-call votes 0

No roll-call votes recorded for this measure.

Timeline 1

Date	Chamber	Action
September 4, 2025	House	Referred to Health

Data: Open States (API v3; public data, attribution appreciated), updated November 5, 2026. Official record: palegis.us. Bill pages link to the official text, not copied.

Sources for this page

Open States API v3 (Plural Policy): https://v3.openstates.org/ — copied November 2, 2026

Pennsylvania General Assembly: https://www.palegis.us/legislation/bills — copied November 2, 2026

Bill, action and roll-call data from Open States (public data, attribution appreciated). Neither Pennsylvania Capitol Guide nor this information, as presented here, is endorsed by the Pennsylvania General Assembly.